Your browser doesn't support javascript.
loading
Effects of Combination Denosumab and High-Dose Teriparatide Administration on Bone Microarchitecture and Estimated Strength: The DATA-HD HR-pQCT Study.
Ramchand, Sabashini K; David, Natalie L; Lee, Hang; Bruce, Michael; Bouxsein, Mary L; Leder, Benjamin Z; Tsai, Joy N.
Affiliation
  • Ramchand SK; Department of Medicine, Endocrine Unit, Massachusetts General Hospital, Harvard University, Boston, MA, USA.
  • David NL; Department of Medicine, Endocrine Unit, Austin Hospital, The University of Melbourne, Melbourne, Australia.
  • Lee H; Department of Medicine, Endocrine Unit, Massachusetts General Hospital, Harvard University, Boston, MA, USA.
  • Bruce M; Biostatistics Center, Massachusetts General Hospital, Boston, MA, USA.
  • Bouxsein ML; Department of Medicine, Endocrine Unit, Massachusetts General Hospital, Harvard University, Boston, MA, USA.
  • Leder BZ; Department of Orthopedic Surgery, Harvard Medical School, Beth Israel Deaconess Medical Center, Boston, MA, USA.
  • Tsai JN; Department of Medicine, Endocrine Unit, Massachusetts General Hospital, Harvard University, Boston, MA, USA.
J Bone Miner Res ; 36(1): 41-51, 2021 01.
Article in En | MEDLINE | ID: mdl-32790196

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Teriparatide / Bone Density Conservation Agents Type of study: Clinical_trials Limits: Female / Humans Language: En Journal: J Bone Miner Res Journal subject: METABOLISMO / ORTOPEDIA Year: 2021 Document type: Article Affiliation country: Estados Unidos Country of publication: Estados Unidos

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Teriparatide / Bone Density Conservation Agents Type of study: Clinical_trials Limits: Female / Humans Language: En Journal: J Bone Miner Res Journal subject: METABOLISMO / ORTOPEDIA Year: 2021 Document type: Article Affiliation country: Estados Unidos Country of publication: Estados Unidos